Relay Therapeutics Inc (NASDAQ: RLAY) on Monday, soared 7.58% from the previous trading day, before settling in for the closing price of $6.86. Within the past 52 weeks, RLAY’s price has moved between $1.77 and $7.50.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.05%. The company achieved an average annual earnings per share of 22.28%. With a float of $130.15 million, this company’s outstanding shares have now reached $171.69 million.
Relay Therapeutics Inc (RLAY) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Relay Therapeutics Inc is 24.51%, while institutional ownership is 78.63%. The most recent insider transaction that took place on Jul 29 ’25, was worth 57,864. In this transaction an insider of this company sold 15,724 shares at a rate of $3.68, taking the stock ownership to the 377,998 shares. Before that another transaction happened on Jul 28 ’25, when Company’s insider sold 1,359 for $3.74, making the entire transaction worth $5,083. This insider now owns 393,722 shares in total.
Relay Therapeutics Inc (RLAY) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.63 earnings per share (EPS) for the period topping the consensus outlook (set at -0.78) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.46% during the next five years compared to -23.05% drop over the previous five years of trading.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Relay Therapeutics Inc (RLAY) is currently performing well based on its current performance indicators. A quick ratio of 20.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 152.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
The latest stats from [Relay Therapeutics Inc, RLAY] show that its last 5-days average volume of 2.5 million was superior to 2.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 73.63%.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 97.35%, which indicates a significant increase from 92.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.52 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.94, while its 200-day Moving Average is $3.81. Now, the first resistance to watch is $7.53. This is followed by the second major resistance level at $7.67. The third major resistance level sits at $7.95. If the price goes on to break the first support level at $7.10, it is likely to go to the next support level at $6.82. Assuming the price breaks the second support level, the third support level stands at $6.68.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
Market capitalization of the company is 1.27 billion based on 172,411K outstanding shares. Right now, sales total 10,010 K and income totals -337,710 K. The company made 680 K in profit during its latest quarter, and -70,380 K in sales during its previous quarter.
